To better serve customers worldwide with our high-quality genetically modified mouse models, Cyagen has invested heavily in research and development. These efforts helped establish the Cyagen AI Knockout Mouse Model eBank in 2017, which provides gene knockout (KO), conditional knockout (cKO), and point mutation mouse strains with rapid turnaround and competitive prices. To date, our eBank has helped more than 3,000 research groups to accelerate their research progress and benefited 300 companies in drug development. With the continuous advancement of our technological capabilities, service offerings, shorter turnarounds, and more competitive prices, Cyagen AI Knockout Mouse Model eBank has been well received among various renowned laboratories.
■ Promotion Period: September 28th 2020 - October 31st 2020
■ Eligibility: End clients in South Korea, Australia, New Zealand. Other regions, please contact us.
■ Notice: Submitting your target gene to get $1,000 special voucher for conditional gene knockout (cKO) mice, which can be used directly on the same eBank order.
|≥3 cKO Mice||$12,000||$11,000|
|Faster Delivery and Stronger Guarantee: We ensure that you can get the most cost-effective models in the shortest time by generating conventional knockout (KO) and conditional knockout (cKO) mice with a guaranteed genotype from cryopreserved sperm.|
|Higher Cost-efficiency: Cyagen AI Knockout Mouse Model eBank shatters the price barriers of typical gene knockout mice with innovations that enable large-scale preparation of mouse models from a catalog of cryopreserved sperm - enabling more research groups access to high-quality mouse model products.|
|Well-Established Platform: In under 15 years, Cyagen has successfully delivered over 50,000 custom animal models to researchers across the globe. Our catalog is managed by internationally renowned Cyagen scientists, all models have guaranteed genotyping reports available.|
|AAALAC-Accredited and OLAW Assured: The Cyagen Transgenic Animal Center (CTAC) is AAALAC-accredited and OLAW assured - demonstrating Cyagen's adherence to strict guidelines for the care and use of animals. Through international exchanges and cooperation, Cyagen has established and improved its monthly, quarterly, and semi-annual animal health detection mechanisms. In addition to the microorganisms and parasites required by the SPF national standard, we also test for others like helicobacter, Bacillus oxytocus perniciosus, Murine norovirus (MNV), and more.|
|Intelligent Project Management System: Cyagen uses its own intelligent project management system for feeding and breeding project management, every cage has its own two-dimensional code recognition system. Our data-based project management system makes breeding records clear and readable, easy to retrieve, and can store records for a long time.|
|Perfect Training and Quality Management System: Cyagen has established a complete SOP system and a perfected our training program - upholding a strict standard for the operation of technical personnel to ensure the quality of animals and the cleanliness of barriers.|
|Professional Technical Support: Cyagen's project management team will control the process quality in accordance with your preferences or requirements. We provide you with an experimental scheme, regularly send up-to-date project reports, and comprehensive post-delivery consultation services with 24/7 customer support - minimizing both your time and energy spent on project management.|
Dual-targeting Nanoparticle Vaccine Elicits a Therapeutic Antibody Response Against Chronic Hepatitis B.Nature Nanotechnology PMID: 32123380 (2020) IF=33.407
Reducing Hypothalamic Stem Cell Senescence Protects against Aging-Associated Physiological Decline.Cell Metabolism PMID: 32004475 (2020) IF=22.415
In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.Circulation PMID: 31779484 (2019) IF=23.054
Inhibition of S-Adenosyl homocysteineHydrolase Induces Endothelial Dysfunction via Epigenetic Regulation of p66shc-Mediated Oxidative Stress Pathway.Circulation 139(19):2260-2277 (2019) IF=23.054